The EGFR pathway is the dominant regulator of prostate cancer progression, and so we analyzed the regulatory interactions of EGFR ligands with miR-203 and its respective functional roles in TKIs resistance and metastasis. This evidence concerns the gene EGFR and prostate cancer.